420 with CNW — Senate Democrats Implore Feds to Remove Marijuana from CSA

In a recent letter to the U.S. Drug Enforcement Administration (DEA), 12 Senate Democrat legislators have urged President Joseph Biden’s administration to reconsider federal cannabis restrictions as the agency contemplates cannabis rescheduling. The letter, signed by the Senate Majority Leader and spearheaded by Senators Elizabeth Warren and John Fetterman, highlights the strong argument in favor of taking cannabis out of Schedule I. The senators suggest removing it completely from the CSA in addition to downgrading its classification.

In August 2023, the U.S. Department of Health and Human Services (HSS) recommended moving marijuana from Schedule I to III of the Controlled Substances Act (CSA), a move that triggered an ongoing, months-long review process. Rescheduling or descheduling (removing it from the CSA completely) cannabis would significantly impact the cannabis industry as well as cannabis users, some of whom use it medically.

Schedule I, which formally classifies marijuana as a substance with high abuse potential and no recognized medical uses, puts it in the same category as drugs such as LSD and heroin. Despite this, different marijuana laws have been passed by 40 states as well as Washington, D.C., leaving users and businesses in a confusing legal environment.

Last month, the DEA stated that it maintained the authority to deschedule, schedule or reschedule substances under the CSA based on medical and scientific assessments despite the HHS’s recommendation.

The White House hoped for a rescheduling announcement approximately one year following President Biden’s October 2022 order for the DEA to review the HHS’s recommendation report. Though no statement has been made, it was anticipated that the matter would come up frequently during the elections in November.

In their letter, the senators noted that Biden’s administration needs to first take cannabis out of Schedule I before eventually descheduling it. The government officials highlighted the administration’s unique opportunity to conform to public health and scientific rationales while mitigating the negative effects of existing federal cannabis regulations on small enterprises and individuals.

Meanwhile, Senators Ron Wyden and Cory Booker, who are also signatories to the letter, proposed comprehensive cannabis reform aimed at decriminalizing and abolishing the federal prohibition of marijuana. However, the legislation hasn’t received the required bipartisan support.

Another measure, the SAFE Banking Bill, attempts to make it easier for banks to offer financial services to marijuana enterprises in places where the drug is legal. The measure passed through committee but is still awaiting a senate vote. Schumer has previously emphasized the importance of the bipartisan-backed bill as a top legislative priority.

Cannabis companies such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) will be following the developments on Capitol Hill to see whether the legislative front can finally bring reforms beyond what the DEA is expected to announce once its scheduling review is completed.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Illinois Bags $417M in Cannabis Taxes as 2023 Sales Soar to $1.6B

A report recently released by the Illinois Department of Financial and Professional Regulation shows that in 2023, recreational marijuana sales surpassed $1.6 billion. This figure is its highest amount since the state legalized adult-use marijuana in 2019.

The drug’s legalization came after the state’s General Assembly approved the Illinois Cannabis Regulation and Tax Act, which was enacted in 2020.

In addition to being the 11th state to legalize adult-use marijuana in the United States, Illinois was the first state to adopt a regulatory system for marijuana testing, cultivation and sales via a state legislature. The state of Illinois is also the first to legalize recreational marijuana via a measure that also includes a social-equity program.

The growth in sales recorded in 2023 was driven by the significant increase in recreational cannabis products sold, which topped 42 million. This is roughly a 15% increase from the number of recreational cannabis products sold in 2022.

Out-of-state customers bought products worth $408 million while residents in the state purchased products worth $1.2 billion in 2023.

Despite the promising figures, a drop in sales to out-of-state customers was recorded. Authorities in the state attributed the drop to legalization of the drug in neighboring states, including Missouri and Michigan.

According to the state’s department of revenue, roughly $417 million in sales tax revenue was collected. These funds are allotted to the Cannabis Regulation Fund.

A 6.25% retailers’ occupation tax is imposed on all marijuana sales in the state, in addition to taxes levied at the county and municipal levels.

In a statement, Governor JB Pritzker stated that his administration had built the most accessible marijuana industry in the country by putting equity first. He also noted that their work would continue to provide opportunities for communities across the state, repair wrongdoings of the past and create a more prosperous future.

Currently, 177 recreational marijuana dispensaries operate in Illinois.

Of the total number, five are located in the Springfield area. Maribis has two locations on Denver Drive and Lindbergh Drive while Ascend Cannabis also has two locations, one off Dirksen Parkway and another in downtown Springfield. The latest location, situated on 3600 S. 6th Street Road, launched in September 2023.

The city council of Springfield also approved the permits for 2 new locations in 2023. These locations are set to launch this year. Shangri La plans to build a facility on a lot along Dirksen Parkway while Bolden Investments III will open a store on Prairie Crossing. Boden is based in Maywood.

As more licensed cannabis companies such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) consolidate their operations in the state, sales are likely to keep growing as more customers learn to rely on the high-quality products that reputable companies bring to the market.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Retailer Goes to Court Over California’s Cannabis Excise Taxes

Catalyst Cannabis Co., a major marijuana dispensary chain in California, has initiated court action against an emergency rule alteration implemented by state tax authorities in December. The company, operating under the name HNHPC Inc., went to court on Dec. 28, 2023, in the Superior Court of Orange County.

The suit alleges collusion between the state’s fee administration and tax department and the Administrative Law Office, accusing them of two key violations: imposing excise levies on nonmarijuana products such as accessories and exploiting emergency regulatory powers to hastily enforce retroactive regulations without sufficient notice to affected companies.

The crux of the legal challenge revolves around the interpretation of excise taxes on various elements of marijuana products. Taking a vape cartridge as a primary example, the suit claims that excise taxes should exclusively affect the marijuana oil, excluding the entire item, including the packaging and pen mechanism. This exemption would only apply if the vendor itemizes charges for both the marijuana oil plus the nonmarijuana components.

Under this approach, the retailer would only pay the 15% excise tax on the oil, typically valued at around $5, leading to a tax of only 75 cents. Catalyst Cannabis Co., based in Long Beach, California, has been employing this method to calculate excise taxes for more than a year, according to company executives and court documents.

As one of the state’s major cannabis operators, with 25 stores located mainly in Southern California, Catalyst is challenging the state regulators’ position outlined in Emergency Regulation 3802. According to this regulation, excise taxes should also cover “optional tangible personal property.” The broader definition encompasses the entire vape device, packaging and associated components. Consequently, under the state’s directive, a $40 vape pen would incur a $6 excise tax, which is eight times the tax applied solely to the oil.

Catalyst CEO Elliot Lewis, a vocal critic of the state’s marijuana regulations, expressed confidence in the lawsuit’s success. Lewis anticipates that overturning Regulation 3802 could potentially redirect millions back to the both marijuana industry and consumers.

Lewis has received supportive calls from fellow marijuana operators and foresees a ripple effect with other retailers reevaluating their excise tax calculations. He believes that by the second quarter of 2024, excise levy submissions to the state will reflect this recalibration, projecting a significant reduction from an estimated $600 million to around $200 million annually.

In Lewis’s view, the judicial intervention presents a crucial opportunity for relief and reform in the marijuana industry, emphasizing the potential impact on both industry finances and consumer costs.

The outcome of this lawsuit will be of interest to cannabis companies such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) because it could pave the way for similar legal challenges in other jurisdictions where the same formula is used to levy taxes on cannabis products.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — California AG Says Interstate Marijuana Trade Would Attract Federal Enforcement

A recent letter from the California attorney general to state cannabis regulators has pretty much killed any hope of developing the interstate cannabis trade. Attorney General Rob Bonta sent a letter to the California Department of Cannabis Control (DCC) stating that businesses between licensed cannabis businesses in California and out-of-state entities could lead to “significant legal risk to the State of California,” as per the nation’s federal Controlled Substances Act.

Although the controversial plant is legal in dozens of states for either recreational or medical consumption, federal law still classifies the substance as a Schedule I drug with no medical uses and a high potential for abuse. This has put significant barriers to cannabis trade in states with legal markets and has essentially made interstate cannabis trade illegal.

However, with 24 states now allowing recreational cannabis and several more poised to legalize adult use over the decade, interest in interstate cannabis trade has been on the rise. Interstate trade could be beneficial for the industry as businesses could focus on cultivating cannabis in states with suitable climates and sell their products to a much wider market.

Bonta’s letter stopped any hopes of interstate cannabis trade developing in the next couple of years and informed officials that such trade could put the state at significant risk of facing legal federal action. The letter comes months after the attorney general received a request from the state Department of Cannabis Control asking for its assessment of the potential liability of allowing interstate cannabis trade under a 2022 California law passed by Governor Gavin Newsom.

DCC officials asked the California AG for his professional opinion on the measure shortly after it went into effect on Jan. 1, 2023. Although the DCC believes that enacting interstate cannabis trade would not put the state at legal risk, the attorney general’s office says that it can’t rule out the possibility of facing federal action as the Controlled Substances Act expressly prohibits cannabis trade and would supersede Governor Newsom’s law.

Enacted in September 2022, Senate Bill 1326 increased hopes for interstate cannabis trade among cannabis stakeholders in California, but it would have needed several prerequisites to kick in. The measure stated that the governor had the authority to enter into interstate cannabis commerce trade agreements with other states if federal law or guidance was amended or if the state attorney general said there was minimal to little risk of facing “significant legal risk.”

While many states and companies such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) could be interested in interstate cannabis commerce, it appears that until policy changes are made at the federal level, marijuana businesses will be restricted to operating within state borders.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Governor Enacts Law Permitting Cannabis Cultivators to Sell to Patients Directly

Last week, Pennsylvania’s governor signed a measure that would allow all licensed medical cannabis grower-processors to sell their products directly to consumers. This came just days after the Senate approved the measure, which had been amended to grant independent dispensaries grower permits.

Under the bill, the state’s health department will establish a process that allows the 10 independent cannabis grower-processors in the state to apply to acquire dispensary permits for direct commerce. In addition to this, the four independent dispensaries in the state can also obtain permits to grow products in-house.

The bill, sponsored by Senator Chris Gebhard, replaces current regulations that prohibit more than five of the twenty-five grower-processor license holders in the state from holding dispensary licenses.

Under the current law, other holders of the grower-processor licenses have to sell their products to licensed dispensaries so that they can, in turn, be sold to patients. This had given some operators dominance over the state’s medical cannabis industry. With these new changes, it is expected that almost $2 million in revenue from permit and application fees will be generated. In the coming years, Pennsylvania should expect to generate roughly $90,000 a year from the same. Part of this revenue will be allocated to the Department of Health to offset administrative costs.

One provision in the resolution will prohibit licensees from permit transfers, which legislators argue will help prevent bigger companies from buying up permits and gaining monopoly over the market.

It is expected that Pennsylvania may soon legalize the recreational use of marijuana, just as other states in the region have done. Last month, voters in the state of Ohio legalized adult-use marijuana following the passage of the Act to Control and Regulate Adult Use Cannabis. The new measure, which went into effect earlier this month, will permit individuals aged 21 and older in the state to legally use and purchase the drug. Other states, such as New Jersey, legalized adult-use marijuana years ago.

A House committee in Pennsylvania recently held a second informational hearing on cannabis legalization as the call to enact reform continues to grow. Governor Josh Shapiro as well as U.S. Senator John Fetterman stated that the time had come for the state to make the change. Two bipartisan legislators are already looking for cosponsors to support their cause. The legislators, Senators Sharis Street and Camera Bartolotta, recently presented a resolution that would decriminalize cannabis and make simple possession a civil offense instead of a misdemeanor crime.

The ongoing evolution of the cannabis landscape in Pennsylvania is likely to be seen by the industry and leading companies in other jurisdictions such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) as steps in the right direction.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Cultivation, Possession of Cannabis is Now Legal, But Ohioans Have Nowhere to Purchase It

Recreational marijuana sales in Ohio remain in a state of uncertainty following a recent development that permits adults to cultivate and possess marijuana at home but restricts them from legally purchasing it.

This week, Republican Governor Mike DeWine asked lawmakers to establish guidelines for Issue 2, the citizen initiative approved by voters in November, in an attempt to beat the law’s effective date. The state’s House declined to take up the matter despite the Senate’s successful last-minute agreement shortly before the statute went into effect.

Representative Jamie Callender clarified that there is no specific deadline for putting in place a legal sales framework. He emphasized the importance of a thoughtful approach, ensuring sufficient time for a comprehensive examination and resolution of aspects not taking immediate effect.

Representative Bill Seitz defended the adjournment of the House without debating the 160 pages of related legislation, arguing that it was absurd to pass such a significant proposal without adequate review; he emphasized the need for time to work through the difficulties of establishing marijuana sales, taxes and regulatory frameworks.

DeWine expressed concerns about potential adverse scenarios, such as the flourishing of illicit market sales or increased accessibility to cannabis products contaminated with substances such as fentanyl or pesticides.

Last year, legislators had a four-month window in which to act on Issue 2, a citizen-initiated statute, before it could go to the ballot. However, the Republican-controlled legislature opted for inaction, resulting in the November 7 ballot, which ended in a 57% vote in favor of the initiative.

The approved measure permits adults 21 years of age and older to cultivate up to 12 plants per household or 6 plants per individual, as well as to buy and possess up to 2.5 ounces of marijuana. It called for the creation of a legal cannabis purchasing system by the state within nine months, with a 10% tax. Sales proceeds would go toward paying for social-justice initiatives, addiction-treatment centers, dispensary-owning towns, administrative expenses and employment initiatives that boost the marijuana sector.

With the law about to take effect, Senate GOP leaders proposed a significant alteration to the voter-approved provisions, causing dissatisfaction among supporters and raising concerns in the House. The proposed amendments would have eliminated tax money for social-equality programs, reduced the amount of marijuana that may be possessed at one ounce, increased taxes on sales to fifteen percent, prohibited home cultivation, and transferred funds to the state government as a whole.

A deal that was worked out with DeWine and approved by the Senate in a 28-to-2 vote keeps the 15% tax on sales, lowers the maximum THC content permitted in marijuana extracts, reinstates the 2.5-ounce possession limit and permits up to 35% THC in plants. It also takes away the majority of state revenue control. The legislation gained Democratic support by including provisions to expunge criminal records for possession of up to two and a half ounces, requiring kid-safe packaging and prohibiting ads targeting minors — an initiative backed by the governor.

Senate President Matt Huffman defended the compromise as respecting voters’ decisions while addressing crucial concerns. He acknowledged his opposition to cannabis legalization but emphasized the need to comply with the law to prevent the emergence of an illegal market.

Louis Tobin, the Ohio Prosecuting Attorneys Association executive director, states that while there is still confusion surrounding commercial cannabis sales, several provisions of the new Ohio law are instantly enforceable. He highlighted that while it might be challenging to establish probable cause for carrying less than two and a half ounces of marijuana, some activities, such as smoking in cars, carrying more than is allowed, holding private sales and operating a vehicle while intoxicated, remain prohibited.

The evolving recreational marijuana regulatory system in Ohio is likely to be of interest to multistate operators such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) because it could potentially be a market they would consider expanding into.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana Industry Stakeholders Upbeat Regarding Prospects of Ending Section 280E Pains

During a recent panel discussion at MJBizCon, industry insiders expressed hope for a positive shift in the status of marijuana under the Biden administration. The anticipation is that marijuana could be rescheduled, potentially reducing the burdensome taxes imposed on marijuana businesses by Section 280E of the federal tax code.

However, amid this optimism, the panel acknowledged the existing challenges in the industry and the necessity of taking calculated risks to unlock future benefits. An illustrative example is Virgil Grant, an industry veteran who, despite enduring a six-year federal prison sentence for operating a legally sanctioned medical cannabis business in California, remains undeterred in his commitment to the cannabis sector.

Grant, now the CEO of a California marijuana retail chain and cofounder of the California Minority Alliance and the Southern California Coalition, highlighted the ongoing challenges faced by the industry. Recently, his bank closed his account, creating significant obstacles for essential financial operations such as payroll and lease payments. Rather than succumbing to these challenges, Grant is actively advocating for the passage of the SAFER banking bill, emphasizing its potential to facilitate access to crucial services and capital. He also advocates for ending the imposition of Section 280E on marijuana companies, a sentiment shared by fellow industry stakeholders.

At MJBizCon, Grant shared the stage with other prominent figures, including Kim Rivers, CEO of Trulieve Cannabis, and David Mangone, director of policy at the National Cannabis Roundtable. These individuals participated in a session titled “Cannabis Industry Outlook: Trends, Obstacles, and Strategies to Survive,” which delved into the risks undertaken by industry players in the hope of long-term rewards.

For Rivers, the risks involve a substantial investment of $40 million in advocating for adult-use legalization in Florida and pursuing a $143 million tax redemption from the IRS for payments made between 2019 and 2021. Rivers clarified that Trulieve, unlike some companies, has chosen not to defer tax payments under 280E, emphasizing its commitment to paying taxes in full and on time.

Despite these financial risks, Rivers remains optimistic about the potential $150 million IRS refund. “We’ll let you know if any big checks come through,” he said. The overall theme of the session emphasized the resilience required to navigate the current challenges and uncertainties in the cannabis industry.

In the first presentation of the day, MJBizDaily editorial team members presented predictions for the coming year. These included the reclassification of marijuana from Schedule I to III and the possible elimination of Section 280E. Other predictions encompassed the unlikelihood of a takeover of the cannabis industry by major pharmaceutical firms, increased legalization of recreational cannabis in states such as Pennsylvania and Florida, growing interest from investors in the marijuana industry and the diminishing significance of marijuana in the 2024 presidential election due to bipartisan support for federal cannabis reform.

The expected easing of the tax burden on the marijuana industry in the United States would make it possible for industry actors such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) to earn a decent profit from their operations, gaining the financial muscle to push ahead with bringing more innovative products to market.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Governor Hochul Signs Legislation Granting New York Cannabis Businesses Code 280E Tax Relief

Governor Kathy Hochul has signed into law a measure that provides tax relief to cannabis businesses in the state of New York. The measure, which was approved by the Senate and Assembly a few months ago, fills a policy gap left by a separate measure the governor signed in 2022, which included provisions that permitted tax deductions for marijuana businesses in the state.

In summary, the resolution would permit deductions for business expenses incurred by those authorized by the law to sell, distribute or produce medical marijuana or adult-use marijuana products, for purposes of the business corporation tax, the general corporation tax and the unincorporated business tax. A memo attached to this resolution stated that the modification was appropriate as the expenses of marijuana-related businesses couldn’t be deducted for federal purposes.

Legislators in a few other states have been looking into a tax workaround as state-licensed marijuana businesses continue to grapple with considerably higher federal tax rates as a result of prohibition. For instance, lawmakers in Pennsylvania passed a large-scale tax reform measure in October that contained language to offer state-level relief to medical cannabis businesses.

Governor Janet Mills of Maine also signed a measure to separate state tax from the federal policy for marijuana businesses. In addition, Connecticut Governor Ned Lamont also signed a budget resolution that included provisions offering tax relief at the state-level to licensed cannabis businesses as a workaround for the growing industry.

Illinois Governor J.B. Pritzker also signed a budget measure that included provisions that permitted licensed cannabis businesses to take state tax deductions that were currently prohibited under the 280E code. Prior to the moves made by the Connecticut and Illinois governors, New Jersey governor Phil Murphy signed a measure that would permit licensed cannabis businesses to deduct some expenses on their state tax returns as a partial fix.

Legislators in Virginia and Iowa have also pursued similar tax relief measures for their state’s cannabis markets.

A bill that would amend the IRS code and permit state-legal cannabis businesses to take federal tax deductions that were availed to companies in other industries was also reintroduced by Representative Earl Blumenauer in Congress. At the federal level, however, cannabis businesses in legal states are still not allowed to make federal deductions under Section 280E of the Internal Revenue Code. This is primarily because marijuana remains classified as a Schedule I substance under the Controlled Substances Act.

This issue can be resolved if the DEA considered the recommendations made by the Department of Health and Human Services and reclassified cannabis under Schedule III.

These efforts to provide a measure of tax relief to cannabis companies is a step in the right direction and enterprises such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) could use the funds they save in this way to avail more product options to their customers.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Ohio Vote Means Recreational Cannabis Now Legal in 24 States

Ohio voters gave their approval last week to the legalization of recreational marijuana cultivation and sales, opening the doors to a potentially lucrative market in the Midwest. This milestone was achieved with around 53% of the votes counted, where supporters of Issue 2 were leading with 55.7% in favor against 44.3% opposed.

This makes Ohio the 24th state to legalize recreational marijuana following a prolonged and contentious process. It is expected that the new recreational cannabis market could generate revenues close to $2 billion within the first year of operation, ultimately increasing to $4 billion by the fourth year, according to MJBizDaily.

However, it remains to be seen how things turn out, as the state’s GOP-dominated General Assembly has expressed intentions to make key adjustments or even repeal voter-approved causes. Despite potential legislative challenges, polls indicated strong support for recreational cannabis legalization and sales leading up to the election.

Ohio’s decision to legalize recreational cannabis follows similar decisions by Minnesota and Delaware, which made legalization through their legislatures earlier in the year.

The passing of this legislation is expected to open up new opportunities for vertically integrated multistate operators such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) and Acreage Holdings. The substantial population of Ohio, with more than 11 million residents, and its proximity to neighboring states with limited marijuana programs make it a promising market.

Acreage CEO Dennis Curran expressed his excitement about the vote, seeing it as a turning point for both Ohio and the cannabis industry as a whole, marking increased acceptance of cannabis use and a reduction in the stigma surrounding the plant. Issue 2 introduces several key provisions, including allowing level 1 and 2 cannabis license holders to add three more stores and expand manufacturing and cultivation operations. Recreational cannabis sales will be subject to a 10% excise tax in addition to an existing 5.75% sales tax.

Although Ohio has yet to develop a social-equity program, Issue 2 dedicates a portion of marijuana tax revenue to create opportunities for disadvantaged applicants. The measure also establishes a state agency to formulate and oversee rules and regulations for recreational marijuana, which must be developed within nine months.

While Issue 2 had its proponents, it also faced opposition from various Ohio organizations, including the Manufacturers’ Association of Ohio, the Business Roundtable of Ohio and the Chamber of Commerce, which expressed concerns about workplace safety and the difficulty in finding workers who can pass drug tests. Governor Mike DeWine was also opposed to the legislation.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Predicts $260M Addition to Ohio’s Economy After Cannabis Legalization

Despite differing opinions among ardent supporters, cannabis legalization in Ohio could entail certain drawbacks. Nonetheless, an economic analysis published last week suggests that the advantages would surpass these drawbacks by a yearly sum of $250 million. Issue 2, a proposal to legalize recreational cannabis in Ohio, is set for the upcoming election on Tuesday.

A study conducted by Scioto Analysis sought to assess the potential benefits and drawbacks of such a step in a state where medical cannabis is already legal. To conduct the analysis, the research group drew on findings from states such as Colorado and Washington, where recreational cannabis has been legal for some time. To understand how the advantages and disadvantages identified in those states might apply to Ohio, the researchers used demographic and economic data, as well as crime statistics.

The most significant advantage they identified relates to the additional revenue that Issue 2’s passage would generate, thanks to its 10% excise tax in addition to Ohio’s regular sales tax. However, the report clarifies that the benefit doesn’t solely stem from the anticipated yearly tax revenue of $190 million but rather from how a substantial portion of these funds would be utilized.

According to the report, benefits are realized when services and goods procured by governments yield positive spillover effects. The researchers pinpointed positive spillovers from the 25% and 36% of Issue 2’s revenue allocated to the Substance Abuse Addiction and Marijuana Social Equity and Jobs Funds, respectively. Drawing from analyses of similar funds in other states, the group estimated that the Ohio equity and jobs fund would generate $5.76 in benefits for every dollar spent, and the substance abuse fund would yield $9.19. The report suggests that directing revenue to these two funds could potentially create $820 million worth of benefits for Ohioans annually.

Additionally, the new industry would directly create jobs. The report projects approximately $190 million in wage benefits during the first year of legalization for workers across the state, encompassing both full-time and part-time positions.

Recreational marijuana users would also enjoy benefits, as Issue 2 would reduce the annual marijuana expenditure of this group by $98 million compared to what they would pay otherwise. Furthermore, the legalization of recreational marijuana would likely lead to a reduction in arrests.

When it comes to the cons, one significant drawback is the decrease in worker productivity observed in states where legalization has already occurred. Citing a study from 2017, the report suggests that average productivity per worker dipped by just over 1% in certain industries in states that legalized recreational cannabis. Monetarily, this translates to roughly $900 of lost productivity per worker in Ohio. The report utilized federal employment data to estimate that legalization could cost Ohio workers approximately $760 million in lost productivity in the first year alone.

Moreover, concerns about public safety emerge with the possibility of more intoxicated drivers on the roads, leading to increased accidents causing injuries, property damage and even fatalities. The report estimates an additional 1,700 intoxicated-driving arrests annually in Ohio, with an associated cost of $130 million.

Considering these positives and negatives, the study suggests that if Issue 2 is passed, Ohioans could potentially gain annual benefits of $260 million.

This analysis of the forecast benefits of ending marijuana prohibition in Ohio goes to show what an impact companies such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) might have once a legal cannabis market is launched and entrepreneurs are allowed to address the needs of customers.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com